Switch to:
More From Other Websites
World Leading Clinical Expert to Present to Shareholders Oct 16 2014
Isis Pharmaceuticals Unveils Mid-Stage Data on ISIS-SMNRx Oct 13 2014
Jim Cramer's Top Stock Picks: ISIS KMB PG MNK Oct 11 2014
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan Oct 10 2014
NASDAQ Slides 1.2%; Manitowoc Shares Dip Following Cautious Outlook Oct 10 2014
Markets Mixed; Fastenal Earnings Meet Estimates Oct 10 2014
Morning Movers: Dow Futures Slump; Tesla Tumbles as D-Day Disappoints Oct 10 2014
-Isis launches pivotal trial of drug for rare spine disorder Oct 10 2014
Isis Pharmaceuticals Reports Data From ISIS-SMN Rx Phase 2 Studies in Infants and Children With... Oct 10 2014
Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx Oct 09 2014
Isis Pharmaceuticals joint venture with GSK earns $18 million milestone payment Oct 08 2014
Businesses with name 'Isis' fight bad brand image Oct 03 2014
Businesses with name 'Isis' fight bad brand image Oct 03 2014
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle... Oct 02 2014
Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx Oct 01 2014
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential Sep 25 2014
Isis Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable Sep 24 2014
Isis Pharmaceuticals Up on $4M Milestone Payment Sep 22 2014
Jim Cramer's Top Stock Picks: ISIS DD CY Sep 18 2014
Jim Cramer's 'Mad Money' Recap: Hooray for the Federal Reserve Sep 17 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK